Wei, Yanfei
Li, Guanzhang
Feng, Jing
Wu, Fan
Zhao, Zheng
Bao, Zhaoshi
Zhang, Wei
Su, Xiaodong
Li, Jiuyi
Qi, Xueling
Duan, Zejun
Zhang, Yunqiu
Vega, Sandra Ferreyra
Jakola, Asgeir Store
Sun, Yingyu
Carén, Helena
Jiang, Tao
Fan, Xiaolong https://orcid.org/0000-0002-6612-0465
Funding for this research was provided by:
National Natural Science Foundation of China (81773015, 82072789)
Key Technologies Research and Development Program (2019YFE0108100)
VINNOVA
Article History
Received: 17 April 2022
Accepted: 28 March 2023
First Online: 13 April 2023
Declarations
:
: Fresh tumor samples were obtained from Beijing Tiantan Hospital with the consent from the patients and approval of the ethical committee at Beijing Tiantan Hospital Affiliated to Capital Medical University (KY 2020–093-02). Archived FFPE samples were obtained from Sanbo Brain Hospital, Capital Medical University in Beijing with the approval of the ethical committee at Sanbo Brain Hospital (SBNK-YJYS-2020–014-01). FFPE samples for DNA methylation analysis were obtained from Sahlgrenska University Hospital in Gothenburg, Sweden, with the approval of the local ethical committee (Dnr 1067–16, 604–12). Research was conducted in accordance with the principles of the Helsinki Declaration. All patients provided written informed consent to participate.
: Not applicable.
: The authors declare that they have no competing interests.